Trial Details
Not RecruitingBasic Information
| Clinical ID | c5070 |
|---|---|
| Identifier | EUCTR2019-000852-32-NL |
| Trial Title | A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn Disease that failed conventional treatment: The LDN Crohn study. - The LDN Crohn study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory Bowel Disease, Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Naltrexone hydrochloridePharmaceutical Form: TabletPharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use |
Participant Information
| Sponsor | ErasmusMC |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |